Consensus Virbac

Equities

VIRP

FR0000031577

Market Closed - Euronext Paris Other stock markets 11:36:43 2024-04-19 am EDT			5-day change	1st Jan Change
376 ^EUR	+0.80%		+3.01%	+4.59%

Apr. 17	VIRBAC : A healthy start to 2024; outlook re-iterated
Apr. 17	Virbac: sales up by almost 10% in Q1	CF

Evolution of the average Target Price on Virbac

Price target over the last 5 years

History of analyst recommendation changes

f2d25cc2465ad4.Tf6XzY0qiaxyr2zKHy7X607tkul9cHOZlzcyLRAbmWI.IdPeu_d-7Zwh2wulSxacjwzZ4LpKGDLTwwZRV3tv3A8gyO6svwfh6gX5XA~9be05e46bf6bbfaa4fb6cd4ebc983c85

Analyst Recommendations on Virbac

VIRBAC : A healthy start to 2024; outlook re-iterated	Apr. 17
VIRBAC : Oddo BHF maintains its recommendation on the stock	Mar. 21	CF
VIRBAC : Modest beat in Q4; 2024 outlook maintained	Jan. 18
Stifel Keeps Virbac at Hold, Boosts PT	Jan. 18	MT
VIRBAC : Stifel raises its target price	Jan. 18	CF
VIRBAC : Onboarding some steady improvements	Dec. 22
Virbac: up sharply, a broker raises his target sharply	Dec. 20	CF
Oddo BHF Keeps Virbac at Outperform, Boosts PT	Dec. 20	MT
VIRBAC : Oddo BHF significantly raises its price target	Dec. 20	CF
VIRBAC : On course for a better-than-expected 2023 finish	Dec. 20
VIRBAC : Factoring in the improved 2023 outlook	23-10-26
VIRBAC : A rebound in Q3; outlook improved; markets jubilant	23-10-24
Oddo BHF Upgrades Virbac to Outperform from Neutral, Lifts PT	23-10-24	MT
VIRBAC : H1 profitability pressure less severe than expected	23-10-03
Stifel Downgrades Virbac to Keep from Buy, Cuts PT	23-08-21	MT
VIRBAC : In line Q2; markets coming to terms with the previously-moderated guidance	23-07-19
VIRBAC : Capacity constraints (temporary?) and a market slowdown weigh on near-term earnings	23-07-07
VIRBAC : A French animal healthcare giant investing for the future	23-06-06
VIRBAC : Q1 miss is no major reason to worry	23-04-18
VIRBAC : 2022 ended on a high note but soft 2023 guidance maintained	23-01-20
Roche’s Alzheimer’s failure has sector-wide implications	22-11-14
VIRBAC : Q3 a victim of tough comps and near-term concerns	22-10-19
VIRBAC : A promising animal healthcare play	22-09-28